Medwellai Inc lost $0.25 per diluted share in fiscal year 2026. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q2 FY2026 through Q1 FY2027, the same line adds up to a loss of $0.19 per diluted share. The table below carries 15 fiscal years, from 2013 to 2026, and the quarters Medwellai Inc has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Medwellai Inc lost $0.25 per diluted share in fiscal year 2026.
Medwellai Inc (MWAI) reported a loss of $0.64 per diluted share in fiscal year 2025 and a loss of $0.25 per diluted share in fiscal year 2026. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Medwellai Inc (MWAI) reported a loss of $0.19 per diluted share over the trailing 12 months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.
Medwellai Inc (MWAI) reported -$0.04 in diluted earnings per share in Q1 2027. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Medwellai Inc (MWAI) reported on that line in every period on record.